Biological Material Analysis TRIZ Cases

Antibodies target the KCNK9 extracellular domain to induce internalization, reducing surface expression and inhibiting cancer cell growth.

A CAIX score quantifies carbonic anhydrase IX expression levels in tumor samples to characterize cancer types.

Lectin assays detect specific glycoforms of PSA, CEA, and CA19-9 biomarkers to resolve low sensitivity in early cancer detection.

A calibration function combining a constant and exponential decay terms fits signals from multi-component biological assays to calculate intensive properties.

A contact pad prevents excess conjugate reagent from wicking into the nitrocellulose membrane, ensuring consistent distribution and reliable diagnostic results.

D-amino acid modifications enable FAP detection with specificity over PREP and resistance to inflammatory degradation.

A carrier presents peptides with encoding DNA to identify epitopes binding T-cell receptors.

A mediator system comprising compounds AB detects oxidative stress in biological matrices while avoiding skin toxicity from traditional toxic compounds.

Isolated antibodies bind human B7-H4 to enable specific detection in cancer samples.

Cell surface markers identify human otic progenitors for precise fluorescence-activated cell sorting enrichment.

Recombinant Factor C from CHO cells resists salt inhibition to provide sustainable endotoxin detection without depleting horseshoe crab resources.

Targeting conserved neutralizing epitopes on influenza H5 hemagglutinin provides broad protection against antigenic variation and resistance.

Composite aptamer and graphene oxide nanoparticles enhance measurement precision for Clostridium difficile spores while maintaining simple device complexity.

Novel antibodies bind cell surface GRP78 on tumor cells to inhibit PI3K signaling and induce apoptosis.

Hybridoma clone Z63.5 produces antibodies that recognize native CD63, resolving the lack of unique binding characteristics in existing treatments.

Antibody targets TMEM132A to detect colorectal cancer while sparing normal tissues.

Multiplex immunofluorescence microscopy analyzes CD3, CD8, and FoxP3 spatial clustering in ovarian tumors to predict immunotherapy responsiveness.

A method for sequential epitope detection in formalin-fixed paraffin embedded tissue sections using cyclic antibody labeling and removal.

Antibodies exhibit high CTLA4 affinity in acidic tumor microenvironments while sparing normal tissues, reducing autoimmune side effects.

Enzyme-mediated differential staining generates distinct color products proportional to analyte density in biological samples.

Detergent-treated influenza samples diffuse into antibody gel to quantify hemagglutinin, resolving adjuvant interference in vaccine assays.

A smartphone attachment couples device vibration to a sample cup, tracking particle motion via camera to calculate clotting time.

Fluorescent nanoparticles replace subjective staining to quantify protein levels, resolving dye aggregation issues and improving pCR prediction accuracy.

A diagnostic method using isolated PBMCs and Coxiella burnetii antigens to measure pro-inflammatory cytokine expression levels.

Human serum albumin displaces immunoglobulin G from protein A surfaces at neutral pH, preventing biological sample denaturation during release.

Oligomerizing small protein blocks into trimers reduces the limit of detection by three-fold compared to monolayers.

A label-free method uses enzymatic digestion and mixed-mode chromatography to detect N-linked glycans without fluorescent tags.

Boosted ELISPOT technology determines cytokine levels and chemokine concentrations to distinguish active from latent tuberculosis infections.

A genetically modified cell expresses a hybrid protein with a reporter and control fluorophore to detect botulinum toxin activity.

Fc gamma receptors bind target conjugate pairs to increase association constants and improve immunoassay accuracy.

A diagnostic device uses specific antibodies to react with TSST-1 antigens and form antibody complexes for rapid toxin identification.

A detection system segments analyte signals into digital counting and analog intensity modes to extend measurement capabilities.

Modified nucleotides in X-aptamers resist nuclease digestion while binding SNAP25.

A gas sampling bag integrates an electrochemical test strip with a solid water absorption layer to enable direct pH sensing.

Screen resolves sensitivity versus applicability trade-offs by targeting specific cell surface polypeptides for minimal residual disease monitoring.

An anti-CD73 antibody stimulates B cell differentiation and robust expansion of specific clones to generate diverse antigen-binding antibodies.

GT1b ganglioside reduces batch variability in iPS-derived neurons, replacing animal assays with a precise and ethical cell-based test system.

Antigen-coated solid supports extract interfering therapeutic monoclonal antibodies, enabling accurate electrophoretic detection of disease-related M-proteins.

pH-sensitive dyes change color upon internalization to detect circulating tumor cells, resolving low target concentration bottlenecks in blood samples.

Cooling and heating units condition exhaled air samples to isolate protein markers, addressing low viral load detection challenges in pathogen diagnostics.

Novel monoclonal antibodies bind the inhibin beta-B subunit directly without requiring methionine oxidation.